Showing results (501-510 of 887) with videos related to
Sort By:
Pageof 89
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2024
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trialChristoph Wanner, Masaomi Nangaku, Bettina J Kraus, et al.Ultrasound in Medicine & Biology|December 27, 2008
Heart valve involvement in Fabry cardiomyopathyFrank Weidemann, Joerg M Strotmann, Markus Niemann, et al.The New England Journal of Medicine|March 11, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesHermann Haller, Sadayoshi Ito, Joseph L Izzo, et al.Journal of Hypertension|April 13, 2004
High prevalence and poor control of hypertension in primary care: cross-sectional studyArya M Sharma, Hans-Ulrich Wittchen, Wilhelm Kirch, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 12, 2015
Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 DiabetesMark E Cooper, Vlado Perkovic, Janet B McGill, et al.Lancet (London, England)|March 19, 2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional studyMarkus Ketteler, Philipp Bongartz, Ralf Westenfeld, et al.Cardiovascular Diabetology|November 27, 2020
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Subodh Verma, David Fitchett, et al.Transplantation|February 13, 2015
Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation StudyChristiane Drechsler, Hege Pihlstrøm, Andreas Meinitzer, et al.Advances in Therapy|December 2, 2024
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney CareRicardo Correa-Rotter, Steven J Chadban, Laura Christen, et al.Journal of the American Society of Nephrology : JASN|May 23, 2003
Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoAJan Galle, Alexander Mameghani, Steffen-Sebastian Bolz, et al.Pageof 89